SGRY Earnings

SGRY reported its earnings on 2026-03-02, showcasing a revenue of 885.00M against an estimate of 873.54M, resulting in a 1.31% surprise. The EPS was 0.12, surpassing the expected 0.3 by -60%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following SGRY's earnings announcement on 2026-03-02, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, SGRY's stock price tends to shift by an average of 4.22% in the 10 days leading up to earnings and -1.83% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SGRY's annual revenue to reach 823.15M, while the EPS is projected at -0.01. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SGRY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SGRY's stock price typically moves by 4.22% in the 10 days before its earnings and -1.83% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.01 and revenue of 823.15M.

The earnings call presents a mixed picture. Positive elements include strategic M&A plans, new facility investments, and a share buyback program, indicating confidence. However, challenges such as payer mix issues, slow revenue growth, and cautious guidance offset these positives. The Q&A reveals management's plans to address these challenges, but uncertainty remains. Given the company's market cap and the balance of positive and negative factors, the stock price is likely to remain stable in the short term, resulting in a neutral rating.